Blake Schutter Theil Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Buy
573
+6
+1% +$2.39K 0.17% 97
2026
Q2
$205K Sell
567
-52
-8% -$17.8K 0.14% 109
2026
Q1
$218K Sell
619
-3
-0.5% -$1.07K 0.18% 103
2025
Q4
$204K Buy
+622
New +$197K 0.17% 107

Other funds holding AMGN

Blake Schutter Theil Wealth Advisors's AMGN Position: Q3 2026 in Review

Blake Schutter Theil Wealth Advisors increased its Amgen (AMGN) stake by 1.1% in Q3 2026, buying an estimated $2.39K and bringing the position to 573 shares worth $242K. The position accounts for 0.17% of the portfolio, ranked #97.

Blake Schutter Theil Wealth Advisors first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Blake Schutter Theil Wealth Advisors held 573 shares of Amgen worth $242K as of Q3 2026.
  • Blake Schutter Theil Wealth Advisors bought 6 Amgen shares in Q3 2026, an estimated $2.39K.
  • Amgen made up 0.17% of Blake Schutter Theil Wealth Advisors's portfolio in Q3 2026, its #97 holding.
  • Blake Schutter Theil Wealth Advisors first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Blake Schutter Theil Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.